Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Plitidepsin (Primary)
- Indications Liposarcoma
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms APLIPO
- 25 Jul 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 18 Jun 2013 New trial record